Myriad
Order a GENETIC TESTING KIT
Mutation Prevalence Tables
Hereditary Cancers Genetic Testing Reimbursement/Privacy Resources About Myriad
Melanoma Overview
Identifying Patients
Cancer Risks
Medical Management
Benefits of Testing
Family Matters
FAQs
Search
Site Map
Contact Myriad
Home
Managing Patients with Melanoma
If MELARIS® test results for a patient show an increased risk for melanoma and pancreatic cancer, the following medical management options may help reduce that risk. Preventive measures may be taken following positive test results to help reduce the risk and possibly prevent cancer.
Risk Reduction
Increased Surveillance for Melanoma
Early detection through self-examination and professional evaluation.
Regular full-body skin self-examinations by patient using a hand-held mirror.
Clinical full-body skin exams every 6-12 months, beginning in childhood.
Baseline photography of entire body.
Preventive Surgery for Melanoma
Biopsy and/or removal of suspicious moles.
Preventive Lifestyle Adjustments for Melanoma
Patient should limit exposure to the sun or ultraviolet radiation (e.g. tanning beds).
When going outside the patient should wear protective clothing, such as wide-brimmed hats, sunglasses, and long-sleeved shirts.
Patient should apply sunscreen with a Sun Protection Factor (SPF) of 15 or higher at regular intervals to prevent sunburns, especially in young children.
MELARIS® genetic testing can be provided by your practice or that of a professional genetic risk counselor to help you in the medical management of these high-risk patients. Knowing your patient's genetic status may impact your threshold to biopsy suspicious mole or increase your patient's compliance with skin examinations and sun avoidance behaviors.
» Benefits of MELARIS® Testing

MELARIS is a genetic test for hereditary melanoma
A genetic test for hereditary melanoma